Triiodothyronine antibodies in a case of Graves' disease: long-term follow-up under carbimazole.
Heshmati
H M
HM
Department of Nuclear Medicine, Necker Hospital, Paris, France.
Izembart
M
M
Turpin
G
G
Vallée
G
G
D001323:Autoantibodies / Q000032:analysis*; D002231:Carbimazole / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006111:Graves Disease / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood / Q000276:immunology*
D001323:Autoantibodies; D014284:Triiodothyronine; D002231:Carbimazole; D013974:Thyroxine